WuXi Biologics plunges 24pc after warning of challenges
WuXi's stock has fallen 45 percent this year. SING TAO Bloomberg and staff reporter WuXi Biologics (Cayman) (2269) ...
Read moreWuXi's stock has fallen 45 percent this year. SING TAO Bloomberg and staff reporter WuXi Biologics (Cayman) (2269) ...
Read moreDUBLIN, Nov. 9, 2023 /PRNewswire/ -- The "Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets" report has been added ...
Read moreDublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets" report has been ...
Read moreSHANGHAI, Sept. 8, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, and WuXi XDC, a ...
Read moreRevenue Increased by 17.8% Y-o-Y to RMB8,492.0 Million Adjusted Net Profit Rose by 0.4% to RMB2,925.6 Million Non-COVID Revenue Achieved ...
Read moreSolskin The WuXi PharmaTech family of publicly listed companies, emerging as global leaders in outsourced contract services for drug developers, ...
Read moreContract research, development, and manufacturing organisation (CRDMO) WuXi Biologics has announced a proposed spin-off and separate listing of its subsidiary ...
Read moreHong Kong - WuXi Biologics ('WuXi Bio') (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced ...
Read more(Yicai Global) July 10 -- Shares of WuXi Biologics rose after the Chinese drug developer said it intends to spin ...
Read moreChinese contract research, development and manufacturing organization WuXi Biologics (2269. HK) on Sunday announced the proposed spin-off and separate listing ...
Read moreWe publish a comprehensive news feed covering all news relevant to the crypto user, covering main industry news, politics and regulation as well as consumer-level “news you can use” (practical stuff), including handy DIY tips, links to useful tools, unbiased reviews and opinions revolving around cryptocurrency. Simple logic and real-world examples are preferred before technical jargon and personal rants.